Nature: Tackle Nepal’s typhoid problem now
Buddha Basnyat, director of the Oxford University Clinical Research Unit at Patan Hospital

“…[W]ide deployment of a vaccine [for typhoid fever] could be a useful — and lifesaving — measure. As part of the post-earthquake recovery plan, Nepal should kick-start a long-promised vaccination program. … At present, just one typhoid vaccine is approved by the WHO. It would be cheaper for Nepali health officials to deploy an alternative vaccine, not pre-qualified by the WHO. It is unclear why they have not yet done so; perhaps they are reluctant to be seen to be going against WHO guidance. The decision to vaccinate — whichever vaccine is used — must be backed with solid research…” (8/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KFF | twitter.com/kff

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.